CircAGFG1 Sponges MiR-203 to Promote EMT and Metastasis of Non-small-cell Lung Cancer by Upregulating ZNF281 Expression

Overview

Journal Thorac Cancer

Specialties Oncology
Pulmonary Medicine

Date 2019 Jun 28

PMID 31243884

Citations 31

Authors

Yi-Bo Xue

Meng-Qi Ding

Lei Xue

Jin-Hua Luo

Affiliations

Soon will be listed here.

Abstract

The circRNA circAGFG1 is reported to be important in triple-negative breast cancer progression. However, the mechanism of circAGFG1 in non-small-cell lung cancer (NSCLC) remains unknown. In this study, expression of circAGFG1 was determined by real-time PCR in 20 pairs of NSCLC tissues and adjacent tissues. Next, functional experiments with circAGFG1 were performed in vitro to evaluate the role of circAGFG1 in tumor metastasis and growth. Meanwhile, a dual luciferase reporter assay, RNA pull-down and RNA immunoprecipitation experiments were used to explore the interaction between circAGFG1 and miR-203. Our results revealed that expression levels of circAGFG1 and miR-203 are upregulated in non-small-cell lung cancer tissues. CircAGFG1 enhances NSCLC cell proliferation, invasion, migration and epithelial-mesenchymal transition in vitro. Mechanistic analyses indicated that circAGFG1 acts as a sponge for miR-203 to repress the effect of miR-203 on its target, ZNF281. In conclusion, our study suggests that circAGFG1 promotes NSCLC growth and metastasis though a circAGFG1/miR-203/ZNF281 axis and may represent a novel therapeutic target.

Citing Articles

Non-coding RNAs and exosomal non-coding RNAs in lung cancer: insights into their functions.

Lv X, Yang L, Xie Y, Momeni M Front Cell Dev Biol. 2024; 12:1397788.

PMID: 38859962 PMC: 11163066. DOI: 10.3389/fcell.2024.1397788.

Long non-coding RNAs in drug resistance across the top five cancers: Update on their roles and mechanisms.

Shi Y, Adu-Amankwaah J, Zhao Q, Li X, Yu Q, Bushi A Heliyon. 2024; 10(5):e27207.

PMID: 38463803 PMC: 10923722. DOI: 10.1016/j.heliyon.2024.e27207.

Single-cell transcriptomic analysis of human pleura reveals stromal heterogeneity and informs models of mesothelioma.

Obacz J, Valer J, Nibhani R, Adams T, Schupp J, Veale N Eur Respir J. 2024; 63(1).

PMID: 38212075 PMC: 10809128. DOI: 10.1183/13993003.00143-2023.

Unlocking the predictive potential of long non-coding RNAs: a machine learning approach for precise cancer patient prognosis.

Mo Y, Adu-Amankwaah J, Qin W, Gao T, Hou X, Fan M Ann Med. 2023; 55(2):2279748.

PMID: 37983519 PMC: 11571739. DOI: 10.1080/07853890.2023.2279748.

CircRNA hsa_circ_0070659 predicts poor prognosis and promotes non-small cell lung cancer (NSCLC) progression via microRNA-377 (miR-377) / Ras-Associated Binding Protein 3C (RAB3C) pathway.

Meng Q, Li Y, Sun Z, Yang X Bioengineered. 2023; 13(6):14578-14594.

PMID: 36694911 PMC: 9995125. DOI: 10.1080/21655979.2022.2091572.

References

Law D, Du M, Law G, Merchant J . ZBP-99 defines a conserved family of transcription factors and regulates ornithine decarboxylase gene expression. Biochem Biophys Res Commun. 1999; 262(1):113-20. DOI: 10.1006/bbrc.1999.1180. View

Karginov F, Conaco C, Xuan Z, Schmidt B, Parker J, Mandel G . A biochemical approach to identifying microRNA targets. Proc Natl Acad Sci U S A. 2007; 104(49):19291-6. PMC: 2148283. DOI: 10.1073/pnas.0709971104. View

Garzon R, Marcucci G, Croce C . Targeting microRNAs in cancer: rationale, strategies and challenges. Nat Rev Drug Discov. 2010; 9(10):775-89. PMC: 3904431. DOI: 10.1038/nrd3179. View

Salmena L, Poliseno L, Tay Y, Kats L, Pandolfi P . A ceRNA hypothesis: the Rosetta Stone of a hidden RNA language?. Cell. 2011; 146(3):353-8. PMC: 3235919. DOI: 10.1016/j.cell.2011.07.014. View

Kasinski A, Slack F . Epigenetics and genetics. MicroRNAs en route to the clinic: progress in validating and targeting microRNAs for cancer therapy. Nat Rev Cancer. 2011; 11(12):849-64. PMC: 4314215. DOI: 10.1038/nrc3166. View

Shash E, Peccatori F, Azim Jr H . Optimizing the use of epidermal growth factor receptor inhibitors in advanced non-small-lung cancer (NSCLC). J Thorac Dis. 2012; 3(1):57-64. PMC: 3256492. DOI: 10.3978/j.issn.2072-1439.2010.12.05. View

Hahn S, Hermeking H . ZNF281/ZBP-99: a new player in epithelial-mesenchymal transition, stemness, and cancer. J Mol Med (Berl). 2014; 92(6):571-81. DOI: 10.1007/s00109-014-1160-3. View

Ma M, Chu B, Zhang Y, Weng M, Qin Y, Gong W . Long non-coding RNA CCAT1 promotes gallbladder cancer development via negative modulation of miRNA-218-5p. Cell Death Dis. 2015; 6:e1583. PMC: 4669740. DOI: 10.1038/cddis.2014.541. View

Hashemi Z, Khalili S, Moghadam M, Sadroddiny E . Lung cancer and miRNAs: a possible remedy for anti-metastatic, therapeutic and diagnostic applications. Expert Rev Respir Med. 2017; 11(2):147-157. DOI: 10.1080/17476348.2017.1279403. View

10.

Florczuk M, Szpechcinski A, Chorostowska-Wynimko J . miRNAs as Biomarkers and Therapeutic Targets in Non-Small Cell Lung Cancer: Current Perspectives. Target Oncol. 2017; 12(2):179-200. DOI: 10.1007/s11523-017-0478-5. View

11.

He J, Xie Q, Xu H, Li J, Li Y . Circular RNAs and cancer. Cancer Lett. 2017; 396:138-144. DOI: 10.1016/j.canlet.2017.03.027. View

12.

Lim J, Ibaseta A, Fischer M, Cancilla B, OYoung G, Cristea S . Intratumoural heterogeneity generated by Notch signalling promotes small-cell lung cancer. Nature. 2017; 545(7654):360-364. PMC: 5776014. DOI: 10.1038/nature22323. View

13.

Qian Y, Li J, Xia S . ZNF281 Promotes Growth and Invasion of Pancreatic Cancer Cells by Activating Wnt/β-Catenin Signaling. Dig Dis Sci. 2017; 62(8):2011-2020. DOI: 10.1007/s10620-017-4611-1. View

14.

Switlik W, Szemraj J . Circulating miRNAs as non-invasive biomarkers for non-small cell lung cancer diagnosis, prognosis and prediction of treatment response. Postepy Hig Med Dosw (Online). 2017; 71(0):649-662. DOI: 10.5604/01.3001.0010.3845. View

15.

Chi Y, Jin Q, Liu X, Xu L, He X, Shen Y . miR-203 inhibits cell proliferation, invasion, and migration of non-small-cell lung cancer by downregulating RGS17. Cancer Sci. 2017; 108(12):2366-2372. PMC: 5715240. DOI: 10.1111/cas.13401. View

16.

Zhu Y, Zhou Q, Zhu G, Xing Y, Li S, Ren N . GSK-3β phosphorylation-dependent degradation of ZNF281 by β-TrCP2 suppresses colorectal cancer progression. Oncotarget. 2017; 8(51):88599-88612. PMC: 5687630. DOI: 10.18632/oncotarget.20100. View

17.

Han B, Chao J, Yao H . Circular RNA and its mechanisms in disease: From the bench to the clinic. Pharmacol Ther. 2018; 187:31-44. DOI: 10.1016/j.pharmthera.2018.01.010. View

18.

Zhu Q, Lu G, Luo Z, Gui F, Wu J, Zhang D . CircRNA circ_0067934 promotes tumor growth and metastasis in hepatocellular carcinoma through regulation of miR-1324/FZD5/Wnt/β-catenin axis. Biochem Biophys Res Commun. 2018; 497(2):626-632. DOI: 10.1016/j.bbrc.2018.02.119. View

19.

Geng Y, Jiang J, Wu C . Function and clinical significance of circRNAs in solid tumors. J Hematol Oncol. 2018; 11(1):98. PMC: 6069963. DOI: 10.1186/s13045-018-0643-z. View

20.

Li Y, Hu J, Li L, Cai S, Zhang H, Zhu X . Upregulated circular RNA circ_0016760 indicates unfavorable prognosis in NSCLC and promotes cell progression through miR-1287/GAGE1 axis. Biochem Biophys Res Commun. 2018; 503(3):2089-2094. DOI: 10.1016/j.bbrc.2018.07.164. View